TY  - GEN
AU  - Wu,Xifeng
AU  - Gu,Jian
AU  - Wu,Tsung-Teh
AU  - Swisher,Stephen G
AU  - Liao,Zhongxin
AU  - Correa,Arlene M
AU  - Liu,Jun
AU  - Etzel,Carol J
AU  - Amos,Christopher I
AU  - Huang,Maosheng
AU  - Chiang,Silvia S
AU  - Milas,Luke
AU  - Hittelman,Walter N
AU  - Ajani,Jaffer A
TI  - Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer
SN  - 1527-7755
PY  - 2006///0821
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Carcinoma, Squamous Cell
KW  - Chemotherapy, Adjuvant
KW  - Critical Pathways
KW  - DNA-Binding Proteins
KW  - Dose Fractionation, Radiation
KW  - Esophageal Neoplasms
KW  - Esophagectomy
KW  - methods
KW  - Esophagogastric Junction
KW  - Female
KW  - Fluorouracil
KW  - administration & dosage
KW  - Genes, MDR
KW  - Genotype
KW  - Humans
KW  - Male
KW  - Methylenetetrahydrofolate Reductase (NADPH2)
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Odds Ratio
KW  - Platinum Compounds
KW  - Polymorphism, Single Nucleotide
KW  - Predictive Value of Tests
KW  - Prognosis
KW  - Proportional Hazards Models
KW  - Radiotherapy, Adjuvant
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Stomach Neoplasms
KW  - Survival Analysis
KW  - Taxoids
KW  - Treatment Outcome
KW  - X-ray Repair Cross Complementing Protein 1
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2005.03.6640
ER  -